There are no reported cases of RGNT within the third ventricle, although this tumor has also been described in the pineal region, the tectum and within the aqueduct 2 . Supratentorial localization is quite rare, with only three published: one was found in the septum pellucidum 3 , another within the optic nerve in neurofibromatosis type 1 (NF1) patient 
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were no other neurological symptoms. On examination, his cranial nerves were all intact with no papilloedma. The remainder of the exam showed normal power, reflexes, coordination, and sensation in both upper and lower extremities.
Imaging. An initial non-contrast computed tomography (CT) scan of the head demonstrated obstructive hydrocephalus. Subsequent magnetic resonance imaging (MRI) of the brain (Figure 1) , confirmed hydrocephalus but also demonstrated a lesion within the posterior aspect of the third ventricle. The lesion was isointense on T1 weighted sequences and hyperintense on T2 weighted sequences with a heterogeneous enhancement pattern following administration of gadolinium.
Operation. Given the progressive nature of the patient's symptoms, a decision was made to proceed with endoscopic third ventriculostomy (ETV) and biopsy of the lesion. The procedure was done using a flexible endoscope (Storz). By flexing the endoscope underneath the massa intermedia of the thalami, the tumor was visualized in the aqueductal recess, attached to the right thalamus ( Figure 2 ). Three small biopsy samples were obtained. The endoscope was then directed 
Case 2
History and Physical Examination. A 28-year-old previously healthy male presented with headaches over the previous six weeks. The headache was worse with cough. He developed diplopia three days prior to his presentation. Examination revealed mild bilateral lateral gaze palsy. The remainder of the neurologic exam was otherwise normal.
Imaging. CT head and MRI showed enlargement of the third and lateral ventricles due to an expansile mass in the posterior third ventricle extending into the aqueduct. However, the possibility of this lesion arising from the aqueduct and extending into the posterior third ventricle was feasible. The lesion was hypointense on T1weighted sequence and hyperintense on T2 weighted sequence. Nodular enhancement in the centre of the lesion was seen following administration of gadolinium ( Figure  4 A, and B) .
Operation. Endoscopic third ventriculoscopy (ETV) and biopsy of the lesion was undertaken. Storz flexible scope was utilized for the procedure. The scope was flexed to visualize the tumor within the aqueductal recess. Three small biopsy samples were obtained with no bleeding. Endoscopic third ventriculoscopy was performed following the biopsy. An external ventricular drain was not required. the perivascular pseudorosettes ( Figure 5C and Figure 6C ). The piloid glial component consists of mildly hypercellular sheets of spindled cells with intervening columns and clusters of oligodendroglial-like cells and fields of microcyst formation ( Figure 6A ), this glial component shows immunoreactivity for glial fibrillary acidic protein ( Figure 5D ). Rosenthal fibers and eosinophilic granular bodies are not observed, nor is the IDH-1 R132H mutation identified by immunohistochemistry. Mitotic figures are absent and proliferation analysis utilizing MIB-1 antibody discloses a labelling index of approximately 3% in Case 1 and less than 1% in Case 2. However, in both cases the small biopsied tissues were not enough for 1p/19q testing after they were used for the routine studies. The oligodendrogliomalike genetic profile is unlikely to be seen in RGNT 3 , given the nature of this entity with those typical diagnostic features particularly of neurocytes forming rosettes and absence of IDH-1 R132 mutation.
DISCUSSION
The differential diagnosis of posterior third ventricular lesions can be challenging due to the diversity of tumors that arise or extend into this region, either from the third ventricular wall or the pineal region, velum interpositum, surrounding neural parenchyma, tentorium, or the posterior cerebral vasculature 4 . Typical lesions include: astrocytoma, ependymoma, epidermoid tumor, craniopharyngioma, meningiomas or metastasis 4 . Lesions that are extending from the pineal region are generally either germ cell tumors or pineal parenchymal tumors, although glial tumors and metastasis can also be included in the differential diagnosis for this location 4 .
Rosette-forming glioneuronal tumor was included in the WHO Classification of the central nervous system tumors in 2007 1 . In 1995, prior to the WHO designation, Kuchelmeister et al described similar RGNT pathological findings as a form of dysembryoplastic neuroepithelial tumor 1 . In 2002, Komari et al reported 11 cases that had two pathological components. Their paper was the first to use the term rosette-forming glioneuronal tumor 1, 5 . Initial findings in 1998 described this lesion as a papillary neuroglial tumor. 6 Since the inclusion of RGNT in the WHO Classification system, 49 cases have been reported in the English literature prior to April 2012 2 . Rosette-forming glioneuronal tumor are characterized as rare slowly growing tumors 1 
